Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2018;40(8):500-500
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2018;40(9):501-506
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2023;45(9):501-502
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2003;25(7):501-505
DOI 10.1590/S0100-72032003000700006
PURPOSE: to identify Listeria monocytogenes (Lm) in human placentas by immunohistochemistry (IHC) and relate its presence to the histological alterations found on conventional examination, to the pregnancy trimester, age of pregnant women, cases of abortion and premature delivery, and to the occurrence of habitual abortion. METHODS: a retrospective study was carried out at the pathology service of a teaching hospital in the city of Porto Alegre in 2000. The paraffin blocks of 254 placentas, obtained from abortion, premature delivery and full-term birth, were analyzed by conventional histology using hematoxylin and eosin (HE) staining. The IHC assay consisted of a rabbit anti-listeria polyclonal antibody B65420R (Biodesign®) diluted 1:1000, in addition to the avidin-biotin-streptavidin complex; 148 placentas revealed inflammatory disorders, hemorrhage, necrosis and thrombosis. The c² test was used for statistical analysis. RESULTS: Listeria monocytogenes was detected in 33.78% of the placentas analyzed by IHC. Chorioamnionitis and villitis showed significant statistical difference in the positive placentas. Lm occurred in the 1st, 2nd and 3rd trimester of pregnancy. The age of pregnant women, the cases of abortion and/or premature births were not statistically different as to the presence or absence of Lm in the placentas. Habitual abortions occurred in patients with or without Lm in the placental tissue. CONCLUSION: Immunohistochemistry may be used to confirm the histopathological diagnosis of listeriosis in all trimesters of pregnancy.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2005;27(8):501-501
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2005;27(8):501-501
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2020;42(8):501-507
Primary dysmenorrhea is defined asmenstrual pain in the absence of pelvic disease. It is characterized by overproduction of prostaglandins by the endometrium, causing uterine hypercontractility that results in uterine muscle ischemia, hypoxia, and, subsequently, pain. It is the most common gynecological illness in women in their reproductive years and one of the most frequent causes of pelvic pain; however, it is underdiagnosed, undertreated, and even undervalued by women themselves, who accept it as part of themenstrual cycle. It hasmajor implications for quality of life, such as limitation of daily activities and psychological stress, being one of themain causes of school and work absenteeism. Its diagnosis is essentially clinical, based on the clinical history and normal physical examination. It is important to exclude secondary causes of dysmenorrhea. The treatment may have different approaches (pharmacological, nonpharmacological and surgical), but the first line of treatment is the use of nonsteroidal anti-inflammatory drugs (NSAIDs), and, in cases of women who want contraception, the use of hormonal contraceptives. Alternative treatments, such as topical heat, lifestyle modification, transcutaneous electrical nerve stimulation, dietary supplements, acupuncture, and acupressure, may be an option in cases of conventional treatments’ contraindication. Surgical treatment is only indicated in rare cases of women with severe dysmenorrhea refractory to treatment.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2005;27(8):502-502